Study finds increased survival and cure rates for patients with HIV and MDR-TB when infections treated concurrently

April 17, 2018 by Melva Robertson, Emory University

Patients co-infected with HIV and multidrug-resistant tuberculosis (MDR-TB) can achieve similar survival and tuberculosis cure rates to those infected with MDR-TB but not HIV when treated concurrently for both infections, according to a new study published in the journal Clinical Infectious Diseases. The study was led by investigators at the Emory Rollins School of Public Health, in collaboration with Albert Einstein College of Medicine, the University of KwaZulu-Natal and the U.S. Centers for Disease Control and Prevention.

Neel R. Gandhi, MD, associate professor at the Emory Rollins School of Public Health and the Emory School of Medicine, was principal investigator on the study.

The researchers enrolled 206 MDR-TB patients—both with and without HIV—receiving standardized HIV and MDR-TB regimens in South Africa between 2011 and 2015. They studied rates of survival, tuberculosis cure rates, adverse effects of both treatments, changes in CD4 counts (measurement of T-cells in the blood stream), and HIV treatment outcomes among both groups. 

Although previous studies—in which HIV treatment was not universally available for HIV co-infected patients—showed substantially higher rates of death among HIV co-infected MDR-TB patients, the current study found that survival was similar between HIV co-infected and HIV-negative participants when patients were treated for both diseases concurrently. Only a group of participants with low baseline CD4 counts, whose CD4 counts remained low despite receiving HIV treatment, continued to have dramatically higher mortality rates. In contrast, participants with low baseline CD4 counts whose CD4 counts increased with HIV treatment achieved similar survival rates to those enrolled in the study without HIV.

The study also found that there was no difference in adverse events or adherence to treatment between the groups of participants, even though the HIV co-infected participants had the additional pill burden of taking medications for both HIV and MDR-TB.

"Although the World Health Organization currently recommends concurrent treatment of MDR-TB and HIV for co-infected patients, there have not been prospective data to support that recommendation until now," says Gandhi. "Our study provides high-quality data to support the concurrent treatment for MDR-TB/HIV co-infected globally.

Explore further: Combination therapy doubles survival in metastatic lung cancer

Related Stories

Combination therapy doubles survival in metastatic lung cancer

April 16, 2018
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the EGFR or ALK genes, when compared to ...

Intensified Tx doesn't up survival in tuberculous meningitis

January 15, 2016
(HealthDay)—For patients with tuberculous meningitis, intensified antituberculosis treatment is not associated with higher survival than standard treatment, according to a study published in the Jan. 14 issue of the New ...

Lung microbiome similar with/without HIV

August 26, 2015
(HealthDay)—Lung microbiomes are similar in patients with and without HIV, although oral microbiomes do differ significantly, according to a study published online Aug. 6 in the American Journal of Respiratory and Critical ...

Postoperative mortality rates low among patients with HIV prescribed ART

February 25, 2015
Postoperative mortality rates were low among patients infected with the human immunodeficiency virus (HIV) who are receiving antiretroviral therapy (ART), and those mortality rates were influenced as much by age and poor ...

Co-infected HCV and HIV patients receive more effective treatments

July 22, 2015
Researchers have found that using a combination of sofosbuvir and a new drug agent known as daclastasvir is highly successful in treating co-infected hepatitis C (HCV) and HIV patients.

Recommended for you

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.

Why men might recover from flu faster than women

July 17, 2018
Men may recover more quickly from influenza infections because they produce more of a key lung-healing protein, a study from scientists at Johns Hopkins Bloomberg School of Public Health suggests.

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

Scientists a step closer to predicting epidemics

July 13, 2018
Ecologists at the University of Georgia have taken an important step in their efforts to develop an early warning system for infectious disease outbreaks.

Researchers identify target for novel malaria vaccine

July 13, 2018
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.